About this trial
The goal of this clinical trial is to learn if knowing risk for diabetes can help adult patients with prediabetes take steps to get care and prevent diabetes. The main questions it aims to answer are:
* Does a shared-decision making visit with a health care team member to talk about the participant's diabetes risk increase participants' taking steps to prevent diabetes? * Does a simple message in the patient portal about the participant's diabetes risk increase participants' taking steps to prevent diabetes?
Researchers will compare the visit with usual care at the clinic to see if the visit increases participants' taking steps to prevent diabetes. Separately, the researchers will compare the patient message with usual care at the clinic to see if the message increases participants' taking steps to prevent diabetes.
Participants will:
* Complete surveys at the beginning of the study and up to 2 additional surveys * If the participant falls into the shared decision-making group, the participant will have one 30-minute visit with a healthcare team member to talk about risk of diabetes and how to lower it.
Eligibility criteria
Qualifiers
prediabetes based on most recent HbA1c (5.7-6.4%) or fasting plasma glucose (100-125 mg/dL) in prior 12 months
active patient portal account (MyChart)
patient receiving primary care at Johns Hopkins Community Physicians in Frederick
have overweight or obesity (BMI ≥ 25 kg/m2)
Disqualifiers
have diabetes (HbA1c > 6.4% in prior 6 months or on diabetes registry)
have dementia
previously participated in the Diabetes Prevention Program (DPP)
Trial design
Treatments tested in this trial
- Risk Informed Shared Decision-Making Strategy (RISE)
- Low Touch Messaging Strategy (LTM)
Treatment groups
Sponsors and collaborators
Johns Hopkins University
Lead sponsor
American Diabetes Association
Collaborator